An understanding of glycoprotein IIb/IIIa inhibitor pharmacology and attention to patient-specific risk factors, access site management, and anticoagulant dosing can help minimize the bleeding ...

Eptifibatide, a platelet glycoprotein IIb/IIIa inhibitor substantially reduces ischemic complications in coronary stent interventions and could become a routine pre-treatment in stent coronary ...

Platelet counts should be routinely checked 2-4 hours and 12-24 hours following the PCI. GP IIb/IIIa infusion should be discontinued for thrombocytopenia (<100,000 platelets/mm 3 or a >50% ...